Age-dependent Dystrophin Loss and Genetic Reconstitution Establish a Molecular Link between Dystrophin and Heart Performance during Aging

Molecular Therapy

Volumn 19, Issue 10, 2011, Pages 1821-1825

  Townsend, Dewayne ^a   Daly, Michael ^a   Chamberlain, Jeffrey S ^b   Metzger, Joseph M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DYSTROPHIN; MICRODYSTROPHIN; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; AGING; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME RECONSTITUTION; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART PERFORMANCE; HUMAN; HUMAN CELL; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYSTEMIC THERAPY; VIRAL GENE DELIVERY SYSTEM;

MUS;

EID: 80053564689     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.120     Document Type: Article

References (27)

1. Lloyd-Jones, D, Adams, RJ, Brown, TM, Carnethon, M, Dai, S, De Simone, G et al. (2009). Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121:e46-e215.
2. Yang, B, Larson, DF and Watson, R (1999). Age-related left ventricular function in the mouse: analysis based on in vivo pressure-volume relationships. Am J Physiol 277(5 Pt 2): H1906-H1913.
3. Howlett, SE, Grandy, SA and Ferrier, GR (2006). Calcium spark properties in ventricular myocytes are altered in aged mice. Am J Physiol Heart Circ Physiol 290: H1566-H1574.
4. Lakatta, EG and Levy, D (2003). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 107: 346-354. (Pubitemid 36135235)
5. Lakatta, EG (2003). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation 107: 490-497. (Pubitemid 36158054)
6. Vatta, M, Stetson, SJ, Perez-Verdia, A, Entman, ML, Noon, GP, Torre-Amione, G et al. (2002). Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. Lancet 359: 936-941. (Pubitemid 34246384)
7. Badorff, C, Lee, GH, Lamphear, BJ, Martone, ME, Campbell, KP, Rhoads, RE et al. (1999). Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5: 320-326. (Pubitemid 29124369)
8. Abmayr, S and Chamberlain, J (2006). The Structure and Function of Dystrophin. In: Winder, SJ (ed). Molecular Mechanisms of Muscular Dystrophies. Landes Bioscience: Georgetown, TX. pp 14-34.
9. Koenig, M, Monaco, AP and Kunkel, LM (1988). The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53: 219-228.
10. Ervasti, JM and Campbell, KP (1993). A role for the dystrophin- glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122: 809-823. (Pubitemid 23241091)
11. Yasuda, S, Townsend, D, Michele, DE, Favre, EG, Day, SM and Metzger, JM (2005). Dystrophic heart failure blocked by membrane sealant poloxamer. Nature 436: 1025-1029. (Pubitemid 41191686)
12. Towbin, JA, Hejtmancik, JF, Brink, P, Gelb, B, Zhu, XM, Chamberlain, JS et al. (1993). X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87: 1854-1865. (Pubitemid 23165627)
13. Gregorevic, P, Blankinship, MJ, Allen, JM, Crawford, RW, Meuse, L, Miller, DG et al. (2004). Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 10: 828-834. (Pubitemid 39070856)
14. Townsend, D, Blankinship, MJ, Allen, JM, Gregorevic, P, Chamberlain, JS and Metzger, JM (2007). Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure. Mol Ther 15: 1086-1092. (Pubitemid 46813611)
15. Bostick, B, Yue, Y, Long, C and Duan, D (2008). Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression. Circ Res 102: 121-130.
16. Kakarla, SK, Rice, KM, Katta, A, Paturi, S, Wu, M, Kolli, M et al. (2010). Possible molecular mechanisms underlying age-related cardiomyocyte apoptosis in the F344XBN rat heart. J Gerontol A Biol Sci Med Sci 65: 147-155.
17. Nitahara, JA, Cheng, W, Liu, Y, Li, B, Leri, A, Li, P et al. (1998). Intracellular calcium, DNase activity and myocyte apoptosis in aging Fischer 344 rats. J Mol Cell Cardiol 30: 519-535. (Pubitemid 28132731)
18. Matsuzaki, S and Szweda, LI (2007). Inhibition of complex I by Ca2+ reduces electron transport activity and the rate of superoxide anion production in cardiac submitochondrial particles. Biochemistry 46: 1350-1357. (Pubitemid 46208482)
19. Nishimura, M, Ocorr, K, Bodmer, R and Cartry, J (2011). Drosophila as a model to study cardiac aging. Exp Gerontol 46: 326-330.
20. Harper, SQ, Hauser, MA, DelloRusso, C, Duan, D, Crawford, RW, Phelps, SF et al. (2002). Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med 8: 253-261. (Pubitemid 34250103)
21. Bodyak, N, Kang, PM, Hiromura, M, Sulijoadikusumo, I, Horikoshi, N, Khrapko, K et al. (2002). Gene expression profiling of the aging mouse cardiac myocytes. Nucleic Acids Res 30: 3788-3794. (Pubitemid 35012451)
22. Huq, F, Lebeche, D, Iyer, V, Liao, R and Hajjar, RJ (2004). Gene transfer of parvalbumin improves diastolic dysfunction in senescent myocytes. Circulation 109: 2780-2785. (Pubitemid 38737926)
23. Michele, DE, Szatkowski, ML, Albayya, FP and Metzger, JM (2004). Parvalbumin gene delivery improves diastolic function in the aged myocardium in vivo. Mol Ther 10: 399-403. (Pubitemid 39117884)
24. Schmidt, U, del Monte, F, Miyamoto, MI, Matsui, T, Gwathmey, JK, Rosenzweig, A et al. (2000). Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circulation 101: 790-796. (Pubitemid 30100087)
25. Schmidt, U, Zhu, X, Lebeche, D, Huq, F, Guerrero, JL and Hajjar, RJ (2005). In vivo gene transfer of parvalbumin improves diastolic function in aged rat hearts. Cardiovasc Res 66: 318-323. (Pubitemid 40471046)
26. Barnabei, MS, Palpant, NJ and Metzger, JM (2010). Influence of genetic background on ex vivo and in vivo cardiac function in several commonly used inbred mouse strains. Physiol Genomics 42A: 103-113.
27. Blankinship, MJ, Gregorevic, P, Allen, JM, Harper, SQ, Harper, H, Halbert, CL et al. (2004). Efficient transduction of skeletal muscle using vectors based on adenoassociated virus serotype 6. Mol Ther 10: 671-678. (Pubitemid 39272856)